TG Therapeutics, Inc. to Ring the NASDAQ Stock Market Closing Bell

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

ADVISORY, July 10, 2013 (GLOBE NEWSWIRE) -- What: TG Therapeutics, Inc. [TGTX], an innovative, clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of cancer and other underserved therapeutic needs, will visit the NASDAQ MarketSite in Times Square.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC